Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24	3.78e-12	37	142	9	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24	4.93e-12	38	142	9	GO:0070001
GeneOntologyMolecularFunction	zinc ion binding	ERVK-6 PRICKLE4 TRIM51 TRIM75 MARCHF8 SEC24A TUT1 ERVK-7 ERVK-21 CPM ERVK-9 ZRANB3 BRAP TRIM67 P2RX4 ERVK-8 ADAMTS20 ERVK-19 ERVK-24 RABGGTA TOP3A	1.35e-06	891	142	21	GO:0008270
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-8	5.57e-05	11	142	3	GO:0004523
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	TRPM4 TRPM2 P2RX4 TRPM8	6.64e-05	31	142	4	GO:0099604
GeneOntologyMolecularFunction	peptidase activity	USP50 ERVK-6 USP18 ERVK-7 ERVK-21 CPM ERVK-9 ERVK-8 ERVK-18 PAN2 SENP6 ADAMTS20 ERVK-19 ERVK-25 ERVK-24	6.68e-05	654	142	15	GO:0008233
GeneOntologyMolecularFunction	transition metal ion binding	ERVK-6 PRICKLE4 TRIM51 TRIM75 MARCHF8 SEC24A TUT1 ERVK-7 ERVK-21 CPM ERVK-9 ZRANB3 BRAP TRIM67 P2RX4 ERVK-8 ADAMTS20 ERVK-19 ERVK-24 RABGGTA TOP3A	1.02e-04	1189	142	21	GO:0046914
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-8	1.21e-04	14	142	3	GO:0003964
GeneOntologyMolecularFunction	endopeptidase activity	ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 SENP6 ADAMTS20 ERVK-19 ERVK-25 ERVK-24	2.59e-04	430	142	11	GO:0004175
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-8	4.26e-04	21	142	3	GO:0035613
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	TRPM4 TRPM2 CHRNA7 P2RX4 TRPM8 CHRFAM7A	5.00e-04	140	142	6	GO:0099094
GeneOntologyMolecularFunction	ubiquitin-like protein ligase activity	RMND5B AMFR TRIM51 TRIM75 MARCHF8 RNF135 FBXO17 BRAP ZNF451 RNF133	5.69e-04	398	142	10	GO:0061659
GeneOntologyMolecularFunction	ubiquitin-like protein transferase activity	RMND5B AMFR TRIM51 TRIM75 MARCHF8 RNF135 FBXO17 BRAP ZNF451 OBI1 RNF133	1.10e-03	512	142	11	GO:0019787
GeneOntologyMolecularFunction	acyltransferase activity	RMND5B AMFR TRIM51 TRIM75 MARCHF8 RNF135 ZDHHC7 FBXO17 BRAP BAZ1A ZNF451 HHAT OBI1 RNF133	1.27e-03	775	142	14	GO:0016746
GeneOntologyMolecularFunction	nuclease activity	ERVK-6 PNKP ERVK-7 PNLDC1 ZRANB3 ERVK-8 PAN2	1.34e-03	231	142	7	GO:0004518
GeneOntologyMolecularFunction	ubiquitin protein ligase activity	RMND5B AMFR TRIM51 TRIM75 MARCHF8 RNF135 FBXO17 BRAP RNF133	1.40e-03	372	142	9	GO:0061630
GeneOntologyMolecularFunction	aminoacyltransferase activity	RMND5B AMFR TRIM51 TRIM75 MARCHF8 RNF135 FBXO17 BRAP ZNF451 OBI1 RNF133	1.50e-03	532	142	11	GO:0016755
GeneOntologyBiologicalProcess	cell-cell fusion	ERVK-6 ERVK-21 ERVK-9 ERVK-8 CD53 ERVK-19	2.90e-05	85	144	6	GO:0140253
GeneOntologyBiologicalProcess	syncytium formation by plasma membrane fusion	ERVK-6 ERVK-21 ERVK-9 ERVK-8 CD53 ERVK-19	2.90e-05	85	144	6	GO:0000768
GeneOntologyBiologicalProcess	syncytium formation	ERVK-6 ERVK-21 ERVK-9 ERVK-8 CD53 ERVK-19	3.76e-05	89	144	6	GO:0006949
GeneOntologyBiologicalProcess	positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure	CHRNA7 CHRFAM7A	4.84e-05	2	144	2	GO:0001988
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	USP50 FNIP2 MKKS VLDLR RAP1A SYNE1 WNT5A SPTBN2 TRPM2 LRRTM3 CYFIP2 SPTBN5 LIMK2 CYFIP1 P2RX4 MTMR3 PAN2 SENP6 CCN2 CCR7 TBCD	7.98e-05	1189	144	21	GO:0044087
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-8	9.05e-05	13	144	3	GO:0015074
GeneOntologyBiologicalProcess	positive regulation of amide metabolic process	LRRTM3 CHRNA7 TNFRSF1A CHRFAM7A	1.26e-04	37	144	4	GO:0034250
GeneOntologyBiologicalProcess	neuron projection arborization	WNT5A CHRNA7 LRP2 CHRFAM7A	1.40e-04	38	144	4	GO:0140058
GeneOntologyBiologicalProcess	baroreceptor response to decreased systemic arterial blood pressure	CHRNA7 CHRFAM7A	1.45e-04	3	144	2	GO:0001982
GeneOntologyBiologicalProcess	regulation of organelle organization	MKKS PNKP DRD3 MAP6 EML4 SYNE1 WNT5A SPTBN2 TRPM2 CYFIP2 SPTBN5 FZR1 LIMK2 CYFIP1 BUB1B MTMR3 PAN2 SENP6 CCN2 CCR7 TBCD TECPR1	1.56e-04	1342	144	22	GO:0033043
GeneOntologyCellularComponent	vacuolar membrane	FNIP2 VLDLR MARCHF8 TRPM2 RRAGB VAC14 SLCO4C1 P2RX4 CSF3R LRP2 WDFY3 TECPR1 SEC13	5.82e-05	507	146	13	GO:0005774
GeneOntologyCellularComponent	spine apparatus membrane	CHRNA7 CHRFAM7A	1.45e-04	3	146	2	GO:0098897
GeneOntologyCellularComponent	ubiquitin ligase complex	RMND5B AMFR PNKP FBXO17 SKP2 BRAP FZR1 FBXO8 BUB1B MKLN1	1.88e-04	352	146	10	GO:0000151
GeneOntologyCellularComponent	lysosomal membrane	FNIP2 VLDLR MARCHF8 TRPM2 RRAGB SLCO4C1 P2RX4 CSF3R LRP2 TECPR1 SEC13	4.11e-04	462	146	11	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	FNIP2 VLDLR MARCHF8 TRPM2 RRAGB SLCO4C1 P2RX4 CSF3R LRP2 TECPR1 SEC13	4.11e-04	462	146	11	GO:0098852
MousePheno	airway basal cell hyperplasia	CHRNA7 CHRFAM7A	5.59e-05	2	105	2	MP:0011115
MousePheno	abnormal airway basal cell differentiation	CHRNA7 CHRFAM7A	5.59e-05	2	105	2	MP:0011114
MousePheno	abnormal airway basal cell morphology	CHRNA7 CHRFAM7A	5.59e-05	2	105	2	MP:0011113
Domain	TLV_coat	ERVV-2 ERVMER34-1 ERVV-1	1.35e-05	7	138	3	PF00429
Domain	TLV/ENV_coat_polyprotein	ERVV-2 ERVMER34-1 ERVV-1	2.15e-05	8	138	3	IPR018154
Domain	-	RMND5B AMFR TRIM51 MTF2 MARCHF8 RNF135 BRAP TRIM67 BAZ1A MTMR3 WDFY3 OBI1 RNF133	2.91e-05	449	138	13	3.30.40.10
Domain	Znf_RING/FYVE/PHD	RMND5B AMFR TRIM51 MTF2 MARCHF8 RNF135 BRAP TRIM67 BAZ1A MTMR3 WDFY3 OBI1 RNF133	3.66e-05	459	138	13	IPR013083
Domain	Cytoplasmic_FMR1-int	CYFIP2 CYFIP1	5.42e-05	2	138	2	IPR008081
Domain	FragX_IP	CYFIP2 CYFIP1	5.42e-05	2	138	2	PF05994
Domain	WD40_repeat_dom	WDR4 EML4 FZR1 AAAS WDR97 STRN4 PAN2 WDR86 WDFY3 SEC13	7.32e-05	297	138	10	IPR017986
Domain	WD40	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	1.34e-04	259	138	9	PF00400
Domain	Glyco_hormone_CN	MUC5B CCN4 CCN2	1.68e-04	15	138	3	IPR006208
Domain	Cys_knot	MUC5B CCN4 CCN2	1.68e-04	15	138	3	PF00007
Domain	WD40	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	1.73e-04	268	138	9	SM00320
Domain	-	WDR4 EML4 FZR1 AAAS WDR97 STRN4 PAN2 WDR86 WDFY3 SEC13	1.87e-04	333	138	10	2.130.10.10
Domain	WD40_repeat	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	1.93e-04	272	138	9	IPR001680
Domain	WD40/YVTN_repeat-like_dom	WDR4 EML4 FZR1 AAAS WDR97 STRN4 PAN2 WDR86 WDFY3 SEC13	1.96e-04	335	138	10	IPR015943
Domain	LDLR_class-A_CS	VLDLR MAMDC4 MALRD1 LRP2	2.12e-04	40	138	4	IPR023415
Domain	WD40_repeat_CS	EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3	2.19e-04	164	138	7	IPR019775
Domain	WD_REPEATS_1	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	2.27e-04	278	138	9	PS00678
Domain	WD_REPEATS_2	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	2.33e-04	279	138	9	PS50082
Domain	WD_REPEATS_REGION	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	2.33e-04	279	138	9	PS50294
Domain	zf-C3HC4	AMFR TRIM51 MARCHF8 RNF135 BRAP TRIM67 OBI1 RNF133	2.56e-04	223	138	8	PF00097
Domain	Znf_C3HC4_RING-type	AMFR TRIM51 MARCHF8 RNF135 BRAP TRIM67 RNF133	2.93e-04	172	138	7	IPR018957
Domain	CTCK_1	MUC5B CCN4 CCN2	2.97e-04	18	138	3	PS01185
Domain	DUF1394	CYFIP2 CYFIP1	3.22e-04	4	138	2	IPR009828
Domain	DUF1394	CYFIP2 CYFIP1	3.22e-04	4	138	2	PF07159
Domain	Ldl_recept_a	VLDLR MAMDC4 MALRD1 LRP2	3.36e-04	45	138	4	PF00057
Domain	-	VLDLR MAMDC4 MALRD1 LRP2	3.66e-04	46	138	4	4.10.400.10
Domain	LDLRA_1	VLDLR MAMDC4 MALRD1 LRP2	4.31e-04	48	138	4	PS01209
Domain	LDrepeatLR_classA_rpt	VLDLR MAMDC4 MALRD1 LRP2	4.67e-04	49	138	4	IPR002172
Domain	LDLa	VLDLR MAMDC4 MALRD1 LRP2	4.67e-04	49	138	4	SM00192
Domain	LDLRA_2	VLDLR MAMDC4 MALRD1 LRP2	4.67e-04	49	138	4	PS50068
Domain	IGFBP_CNN	CCN4 CCN2	5.34e-04	5	138	2	IPR012395
Domain	CT	MUC5B CCN4 CCN2	5.48e-04	22	138	3	SM00041
Domain	Spectrin	SYNE1 SPTBN2 SPTBN5	6.27e-04	23	138	3	PF00435
Domain	ACTININ_2	SYNE1 SPTBN2 SPTBN5	6.27e-04	23	138	3	PS00020
Domain	ACTININ_1	SYNE1 SPTBN2 SPTBN5	6.27e-04	23	138	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTBN2 SPTBN5	6.27e-04	23	138	3	IPR001589
Domain	Znf_RING	AMFR TRIM51 MARCHF8 RNF135 BRAP TRIM67 BAZ1A OBI1 RNF133	7.20e-04	326	138	9	IPR001841
Domain	Cys_knot_C	MUC5B CCN4 CCN2	8.06e-04	25	138	3	IPR006207
Domain	CTCK_2	MUC5B CCN4 CCN2	8.06e-04	25	138	3	PS01225
Domain	VWC	MUC5B CCN4 CCN2	1.13e-03	28	138	3	PF00093
Domain	Spectrin_repeat	SYNE1 SPTBN2 SPTBN5	1.25e-03	29	138	3	IPR002017
Domain	SPEC	SYNE1 SPTBN2 SPTBN5	1.67e-03	32	138	3	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SPTBN2 SPTBN5	1.67e-03	32	138	3	IPR018159
Domain	PH_dom-spectrin-type	SPTBN2 SPTBN5	1.89e-03	9	138	2	IPR001605
Domain	RING	AMFR TRIM51 RNF135 BRAP TRIM67 BAZ1A OBI1 RNF133	1.96e-03	305	138	8	SM00184
Domain	CTLH_C	RMND5B MKLN1	2.35e-03	10	138	2	IPR006595
Domain	Rap_GAP	SIPA1 SIPA1L2	2.35e-03	10	138	2	PF02145
Domain	CTLH	RMND5B MKLN1	2.35e-03	10	138	2	PS50897
Domain	VWFC_1	MUC5B CCN4 CCN2	2.36e-03	36	138	3	PS01208
Domain	VWFC_2	MUC5B CCN4 CCN2	2.76e-03	38	138	3	PS50184
Domain	VWC	MUC5B CCN4 CCN2	2.76e-03	38	138	3	SM00214
Domain	Rap_GAP_dom	SIPA1 SIPA1L2	2.85e-03	11	138	2	IPR000331
Domain	Insulin_GF-bd_Cys-rich_CS	CCN4 CCN2	2.85e-03	11	138	2	IPR017891
Domain	RAPGAP	SIPA1 SIPA1L2	2.85e-03	11	138	2	PS50085
Domain	IGFBP_N_1	CCN4 CCN2	3.41e-03	12	138	2	PS00222
Domain	VWF_dom	MUC5B CCN4 CCN2	3.67e-03	42	138	3	IPR001007
Domain	F-box-like	FBXO17 SKP2 FBXO8	4.19e-03	44	138	3	PF12937
Domain	TIL_dom	MUC5B LRP2	4.65e-03	14	138	2	IPR002919
Domain	Ldl_recept_b	VLDLR LRP2	4.65e-03	14	138	2	PF00058
Domain	LDLRB	VLDLR LRP2	4.65e-03	14	138	2	PS51120
Domain	LY	VLDLR LRP2	5.34e-03	15	138	2	SM00135
Domain	N2O_reductase_N	FZR1 AAAS	5.34e-03	15	138	2	IPR011045
Domain	LDLR_classB_rpt	VLDLR LRP2	5.34e-03	15	138	2	IPR000033
Domain	ConA-like_dom	TRIM51 RNF135 MAMDC4 MALRD1 TRIM67 WDFY3	5.79e-03	219	138	6	IPR013320
Domain	ZF_RING_1	AMFR TRIM51 RNF135 BRAP TRIM67 OBI1 RNF133	5.94e-03	291	138	7	PS00518
Domain	zf-RING_2	AMFR BRAP RNF133	6.70e-03	52	138	3	PF13639
Domain	ZF_RING_2	AMFR TRIM51 RNF135 BRAP TRIM67 OBI1 RNF133	6.74e-03	298	138	7	PS50089
Domain	MAM	MAMDC4 MALRD1	6.85e-03	17	138	2	SM00137
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVV-2 ERVK-7 ERVK-21 ERVK-9 ERVK-8 ERVK-18 ERVK-19 ERVV-1 ERVK-25 ERVK-24	2.90e-13	94	148	11	21542922
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-21 ERVK-18 ERVK-19	1.30e-12	5	148	5	12629516
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-21 ERVK-9 ERVK-8 ERVK-19	1.01e-09	12	148	5	14557543
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-21 ERVK-9 ERVK-18 ERVK-25 ERVK-24	1.07e-08	18	148	5	18664271
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-18 ERVK-19	7.55e-08	3	148	3	10516026
Pubmed	Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair.	CHRNA7 TLR5 TNFRSF1A CHRFAM7A	1.02e-07	11	148	4	32908007
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-24	3.01e-07	4	148	3	10469592
Pubmed	Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets.	ERVK-6 ERVV-2 ERVV-1	1.50e-06	6	148	3	23085571
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	1.50e-06	6	148	3	15063128
Pubmed	Syncytins expressed in human placental trophoblast.	ERVV-2 ERVMER34-1 ERVV-1	4.16e-06	8	148	3	33504453
Pubmed	Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins.	ERVK-6 ERVK-21 ERVK-19	8.87e-06	10	148	3	12970426
Pubmed	Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons.	TRPM4 TRPM2 TRPM8	1.62e-05	12	148	3	19850157
Pubmed	USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA.	USP50 USP18 PAN2	1.62e-05	12	148	3	27801882
Pubmed	Enhancing cognitive function in chronic TBI: The Role of α7 nicotinic acetylcholine receptor modulation.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	38070724
Pubmed	Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	34453977
Pubmed	Inhibition of pancreatic acinar mitochondrial thiamin pyrophosphate uptake by the cigarette smoke component 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	26999808
Pubmed	Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	27129924
Pubmed	Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	23521765
Pubmed	Effect of α7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	28258105
Pubmed	The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	19344760
Pubmed	Bidirectional Regulation of Aggression in Mice by Hippocampal Alpha-7 Nicotinic Acetylcholine Receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	29114104
Pubmed	Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	33995108
Pubmed	E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	32552811
Pubmed	Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	24836856
Pubmed	Studies of sperm from mutant mice suggesting that two neurotransmitter receptors are important to the zona pellucida-initiated acrosome reaction.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	15948184
Pubmed	Alpha7 nicotinic acetylcholine receptor mediates chronic nicotine inhalation-induced cardiopulmonary dysfunction.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	35678315
Pubmed	Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	12628457
Pubmed	Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	25157794
Pubmed	Mesenchymal Stem Cells or Interleukin-6 Improve Episodic Memory of Mice Lacking α7 Nicotinic Acetylcholine Receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	31202708
Pubmed	Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22246862
Pubmed	Importance of a conserved sequence motif in transmembrane segment S3 for the gating of human TRPM8 and TRPM2.	TRPM2 TRPM8	1.80e-05	2	148	2	23185472
Pubmed	Activation of Nicotinic Acetylcholine Receptors Decreases Apoptosis in Human and Female Murine Pancreatic Islets.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	27471776
Pubmed	Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia.	CYFIP2 CYFIP1	1.80e-05	2	148	2	38128786
Pubmed	Targeting α-7 nicotinic acetylcholine receptor in the enteric nervous system: a cholinergic agonist prevents gut barrier failure after severe burn injury.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22688057
Pubmed	[Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].	CSF2RA CSF3R	1.80e-05	2	148	2	19099633
Pubmed	Different Effects of Nicotine and N-Stearoyl-ethanolamine on Episodic Memory and Brain Mitochondria of α7 Nicotinic Acetylcholine Receptor Knockout Mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	32028688
Pubmed	Activation of α7 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB/c Mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	30429582
Pubmed	A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	21501254
Pubmed	Cardiopulmonary arrest and resuscitation disrupts cholinergic anti-inflammatory processes: a role for cholinergic α7 nicotinic receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	21368056
Pubmed	Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	1400473
Pubmed	Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	26937017
Pubmed	Diminished α7 nicotinic acetylcholine receptor (α7nAChR) rescues amyloid-β induced atrial remodeling by oxi-CaMKII/MAPK/AP-1 axis-mediated mitochondrial oxidative stress.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	36603528
Pubmed	Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	26650489
Pubmed	Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22848433
Pubmed	Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	16650968
Pubmed	Microglial cell response in α7 nicotinic acetylcholine receptor-deficient mice after systemic infection with Escherichia coli.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	35413868
Pubmed	Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	24462939
Pubmed	Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	29261717
Pubmed	Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	18199426
Pubmed	Stroke-induced activation of the α7 nicotinic receptor increases Pseudomonas aeruginosa lung injury.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22490926
Pubmed	Dendritic spine alterations in the hippocampus and parietal cortex of alpha7 nicotinic acetylcholine receptor knockout mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	23270857
Pubmed	Neuronal nicotinic alpha7 receptors modulate inflammatory cytokine production in the skin following ultraviolet radiation.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	18077004
Pubmed	Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling.	SKP2 FZR1	1.80e-05	2	148	2	21212736
Pubmed	Smoking in adult attention-deficit/hyperactivity disorder: interaction between 15q13 nicotinic genes and Temperament Character Inventory scores.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	19462340
Pubmed	Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	16923147
Pubmed	NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	11790782
Pubmed	Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition.	SKP2 FZR1	1.80e-05	2	148	2	17283060
Pubmed	Genetic deletion of α7 nAChRs reduces hippocampal granule and pyramidal cell number in both sexes but impairs pattern separation in males only.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	37746145
Pubmed	A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	19631623
Pubmed	Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	15770102
Pubmed	Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	24326163
Pubmed	Contribution of the S5-pore-S6 domain to the gating characteristics of the cation channels TRPM2 and TRPM8.	TRPM2 TRPM8	1.80e-05	2	148	2	20587417
Pubmed	Dissection of the APCCdh1-Skp2 cascade in breast cancer.	SKP2 FZR1	1.80e-05	2	148	2	18381934
Pubmed	Functional role of alpha7 nicotinic receptor in chronic neuropathic and inflammatory pain: studies in transgenic mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	23811428
Pubmed	Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution.	ERVV-2 ERVV-1	1.80e-05	2	148	2	18826608
Pubmed	Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	20720594
Pubmed	Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	17019565
Pubmed	Dilinoleoylphosphatidylcholine ameliorates scopolamine-induced impairment of spatial learning and memory by targeting alpha7 nicotinic ACh receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	19100751
Pubmed	Activation of the α7 Nicotinic Acetylcholine Receptor Prevents against Microglial-Induced Inflammation and Insulin Resistance in Hypothalamic Neuronal Cells.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	35883638
Pubmed	Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	19368846
Pubmed	Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	15009674
Pubmed	Hydroxynorketamine, but not ketamine, acts via α7 nicotinic acetylcholine receptor to control presynaptic function and gene expression.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	38253622
Pubmed	The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete Freund's adjuvant-induced chronic inflammatory pain.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	34514543
Pubmed	α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22183893
Pubmed	Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	9364063
Pubmed	Evidence suggesting that the mouse sperm acrosome reaction initiated by the zona pellucida involves an alpha7 nicotinic acetylcholine receptor.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	12606407
Pubmed	Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22300029
Pubmed	GTS-21 ameliorates polymicrobial sepsis-induced hepatic injury by modulating autophagy through α7nAchRs in mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	32018068
Pubmed	CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	26206074
Pubmed	Nicotine elicits prolonged calcium signaling along ventral hippocampal axons.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	24349346
Pubmed	The role of nicotinic acetylcholine receptor (nAChR) α7 subtype in the functional interaction between nicotine and ethanol in mouse cerebellum.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	21143250
Pubmed	Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	16319313
Pubmed	Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	25797465
Pubmed	Pharmacologic activation of cholinergic alpha7 nicotinic receptors mitigates depressive-like behavior in a mouse model of chronic stress.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	29197398
Pubmed	Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	38178134
Pubmed	In hippocampal oriens interneurons anti-Hebbian long-term potentiation requires cholinergic signaling via α7 nicotinic acetylcholine receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	23325242
Pubmed	Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22649244
Pubmed	Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	17898229
Pubmed	Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	21901321
Pubmed	Dopamine release in prefrontal cortex in response to beta-amyloid activation of alpha7 * nicotinic receptors.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	17935702
Pubmed	Neuronal nicotinic alpha7 receptors modulate early neutrophil infiltration to sites of skin inflammation.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	20624304
Pubmed	Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	21784975
Pubmed	Lack of acetylcholine nicotine alpha 7 receptor suppresses development of collagen-induced arthritis and adaptive immunity.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	20659128
Pubmed	Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	20843956
Pubmed	Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	10800961
Pubmed	Characterization of allelic variants at chromosome 15q14 in schizophrenia.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	16417613
Pubmed	Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	11834293
Pubmed	Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22314319
Pubmed	Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	34512319
Pubmed	Visual acuity is reduced in alpha 7 nicotinic receptor knockout mice.	CHRNA7 CHRFAM7A	1.80e-05	2	148	2	22281823
GeneFamily	WD repeat domain containing	WDR4 EML4 FZR1 AAAS WDR97 STRN4 WDR86 WDFY3 SEC13	1.36e-05	262	99	9	362
GeneFamily	Ring finger proteins	AMFR TRIM51 TRIM75 MARCHF8 RNF135 BRAP TRIM67 OBI1 RNF133	2.00e-05	275	99	9	58
GeneFamily	CYR61/CTGF/NOV matricellular proteins	CCN4 CCN2	4.39e-04	6	99	2	1046
GeneFamily	Transient receptor potential cation channels	TRPM4 TRPM2 TRPM8	4.72e-04	28	99	3	249
GeneFamily	EF-hand domain containing\|Spectrins	SPTBN2 SPTBN5	6.12e-04	7	99	2	1113
GeneFamily	Low density lipoprotein receptors	VLDLR LRP2	2.23e-03	13	99	2	634
GeneFamily	Ubiquitin specific peptidases	USP50 USP18 PAN2	3.58e-03	56	99	3	366
Coexpression	TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL	FNIP2 MKKS EML4 EMILIN2 CD55 LIMK2 CYFIP1 CSF2RA P2RX4 CSF3R BAZ1A CD53 PCNX1 WDFY3 TNFRSF1A	6.76e-06	724	138	15	M41700
Coexpression	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	TRPM4 IL32 WNT5A LIMK2 BAZ1A CD53 PCNX1 ARAP2	1.14e-05	200	138	8	M3411
CoexpressionAtlas	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K4	USP18 CPM P2RX4 LRP2 CCN2	6.46e-06	41	137	5	mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K4
CoexpressionAtlas	alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3	ADGRG5 CD55 CPM CD6 CCR7	6.77e-05	66	137	5	GSM605770_100
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1	ADGRG5 CD55 CPM CD6 CCR7	7.28e-05	67	137	5	GSM538414_100
CoexpressionAtlas	CD positive, T.8Nve.Sp.OT1, CD8+ CD45.1+, Spleen, avg-3	ADGRG5 CD55 CPM CD6 CCR7	8.98e-05	70	137	5	GSM605909_100
CoexpressionAtlas	JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#4	USP18 PRICKLE4 IL32 CD55 PKHD1L1 SPTBN5 CFAP54 PIEZO2 P2RX4 CCN2 TECPR1	1.07e-04	428	137	11	JC_hmvEC_1000_K4
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_200	CPM PIEZO2 PDE8B CD53 CCN2 TMEM140 ARAP2	1.07e-04	167	137	7	gudmap_kidney_adult_Mesangium_Meis_200
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500	ACER2 USP18 SYNE1 CPM PIEZO2 P2RX4 PDE8B CD53 CCN2 TMEM140 ARAP2	1.09e-04	429	137	11	gudmap_kidney_adult_Mesangium_Meis_500
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC5B PKHD1L1 PIEZO2 PIK3C2G LRP2 ADAMTS20 ZNF488	1.85e-06	184	139	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC5B PKHD1L1 PIEZO2 PIK3C2G LRP2 ADAMTS20 ZNF488	1.85e-06	184	139	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MUC5B PKHD1L1 PIEZO2 PIK3C2G LRP2 ADAMTS20 ZNF488	1.85e-06	184	139	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	PBMC-Control-cDC_10\|Control / Compartment, Disease Groups and Clusters	IL32 MAP6 WNT5A CENPI CCN2 CCR7 WDR86	1.92e-06	185	139	7	4b5a7450fed912f340da16065c1e65d626dbe8d1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 PDE1B SYNE1 CPM CCN4 PIEZO2 WDR86	2.06e-06	187	139	7	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 PDE1B SYNE1 CPM CCN4 PIEZO2 WDR86	2.06e-06	187	139	7	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	VWA3A MAP6 SYNE1 ARMC2 CFAP54 CCN2 DNAH6	2.72e-06	195	139	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADGRG5 CD55 CSF2RA CD53 ERVV-1 CCR7 CHRFAM7A	2.72e-06	195	139	7	d11d559a3afcb8ae845edea14d4cfeb41d82e165
ToppCell	T_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	IL32 EML4 CYFIP2 CD6 CD53 CCR7 ARAP2	3.00e-06	198	139	7	8372ceed063acad0e219644ddd58abbd1354e734
ToppCell	COVID-19-Myeloid-Migratory_DC\|Myeloid / Condition, Lineage and Cell class	IL32 FBXO17 PIEZO2 CSF2RA CCR7 CHRFAM7A ARAP2	3.00e-06	198	139	7	90f3b227cbc61c268d6d94bc9945a08d83d2d3d5
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	USP18 IL32 EML4 SYNE1 HELB CD6 CCR7	3.10e-06	199	139	7	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CD55 LIMK2 CSF3R BAZ1A PCNX1 WDFY3	3.21e-06	200	139	7	6beabd5bad042d4d65c89c2f537c7376230f7c08
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PLXDC1 SYNE1 CCN4 PDE8B SUSD5 KCNS3 CCN2	3.21e-06	200	139	7	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CD55 LIMK2 CSF3R BAZ1A PCNX1 WDFY3	3.21e-06	200	139	7	026495aa7f1e7528a01d9199475cfc393677fc60
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	PNLDC1 SPTBN5 CD6 STC2 CCR7	3.55e-06	74	139	5	08874e430b4c9fcb2c1758c4178cb0c45671b125
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE1 TRPM2 CYFIP2 CSF2RA CSF3R CD53	7.45e-06	149	139	6	c957ac23ad6343eacce7e6be4a6d3ac043af4f86
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE1 TRPM2 CYFIP2 CSF2RA CSF3R CD53	7.45e-06	149	139	6	4de52569611e63a780cde9bd111d6d9c11a05a11
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWA3A ARMC2 ERVMER34-1 CFAP20DC BUB1B DNAH6	7.74e-06	150	139	6	9cb3332924bd67c966873343c14445e30d3f384f
ToppCell	facs-Spleen-nan-24m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 TRPM2 CSF2RA CSF3R TNFRSF1A DNAH6	9.69e-06	156	139	6	034d4359359a44c205c6931f38a375271ac2752b
ToppCell	facs-Spleen-nan-24m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 TRPM2 CSF2RA CSF3R TNFRSF1A DNAH6	9.69e-06	156	139	6	21267718d3a3dc19988663b6846aed8bb3eae836
ToppCell	facs-Spleen-nan-3m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM2 EMILIN2 SLCO4C1 CSF3R TLR5 TNFRSF1A	9.69e-06	156	139	6	f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1
ToppCell	facs-Spleen-nan-24m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 TRPM2 CSF2RA CSF3R TNFRSF1A DNAH6	9.69e-06	156	139	6	2a4dac4100c0339aad4905b8eaca6e8fe806718b
ToppCell	facs-Spleen-nan-3m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM2 EMILIN2 SLCO4C1 CSF3R TLR5 TNFRSF1A	9.69e-06	156	139	6	f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655
ToppCell	facs-Spleen-nan-3m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM2 EMILIN2 SLCO4C1 CSF3R TLR5 TNFRSF1A	9.69e-06	156	139	6	da4f35353a84d919e683554932f110e29568df33
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ACER2 PLXDC1 GRB7 P2RX4 SUSD5 RASL11B	1.04e-05	158	139	6	c8af8964a140acb2987e3b4906d72c546108d229
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A MUC5B PKHD1L1 PIK3C2G LRP2 TRPM8	1.12e-05	160	139	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A MUC5B PKHD1L1 PIK3C2G LRP2 TRPM8	1.12e-05	160	139	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	10x3'2.3-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	IL32 PLXDC1 PLEKHG4 GPR52 CD6 CCR7	1.80e-05	174	139	6	fee2ee3e888ce71f9f3f05d7dc8aaa9549480205
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 IL32 SYNE1 CD6 SLCO4C1 PDE8B	1.92e-05	176	139	6	5914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL32 SEC24A SENP6 ZNF75A GATD1 WDR86	2.11e-05	179	139	6	6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWA3A SYNE1 CFAP54 CCN2 NRG3 SIPA1L2	2.25e-05	181	139	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VWA3A SYNE1 CFAP54 CCN2 NRG3 SIPA1L2	2.25e-05	181	139	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VWA3A SYNE1 CFAP54 CCN2 NRG3 SIPA1L2	2.54e-05	185	139	6	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VWA3A SYNE1 CFAP54 CCN2 NRG3 SIPA1L2	2.54e-05	185	139	6	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-B_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD55 CPM CYFIP2 CD53 CCR7 ARAP2	2.62e-05	186	139	6	d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	ADGRG5 CYFIP2 HELB CD6 CD53 PCNX1	2.70e-05	187	139	6	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ACER2 SYNE1 CPM CCN4 PIEZO2 WDR86	2.78e-05	188	139	6	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1A CD6 CD53 CCR7 ARAP2 TECPR1	2.95e-05	190	139	6	d85b34d19af43d83ebe728f3c7bbefd3792df4a6
ToppCell	T_cells-Effector_memory_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	IL32 PLXDC1 EML4 CD6 PCNX1 WDR86	2.95e-05	190	139	6	13dc3a0aaa554f63eabac37726bd1f11b66fb3dd
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	EML4 CYFIP2 HELB CD6 CD53 PCNX1	2.95e-05	190	139	6	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1B PLXDC1 MUC5B CPM PDE8B ARAP2	2.95e-05	190	139	6	1ab3f19f1ce9f58e5125135704d94655a2e330a0
ToppCell	COVID-19-lung-CD4+_Treg\|lung / Disease (COVID-19 only), tissue and cell type	EML4 CYFIP2 HELB CD6 CD53 CCR7	3.04e-05	191	139	6	73ea3078c1f55cd47e4d99e77b3ce4ff17549d49
ToppCell	facs-Heart-LA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1B PLXDC1 CPM PDE8B WDR86 ARAP2	3.04e-05	191	139	6	a7494191a92984e5f53610bbbedd6714e9169e1c
ToppCell	facs-Heart-LA-24m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1B PLXDC1 CPM PDE8B WDR86 ARAP2	3.04e-05	191	139	6	9c5d88f0d3c834c2419ec3da74652175153ba9df
ToppCell	LV-08._Macrophage\|LV / Chamber and Cluster_Paper	TRPM2 CPM CSF2RA CSF3R CD53 ARAP2	3.13e-05	192	139	6	7be12d580aaf2f2f1562203fcad3a44639b8c5a6
ToppCell	tumor_Lung-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	ADGRG5 TRPM2 CD6 CSF2RA CD53 CCR7	3.22e-05	193	139	6	8cc7172c327a9cf6823e1a35322a4e5960826ec8
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	TRPM2 CPM CSF2RA CSF3R BUB1B CD53	3.22e-05	193	139	6	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	CD55 CPM CSF2RA CSF3R CD53 PCNX1	3.22e-05	193	139	6	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EML4 CYFIP2 HELB CD6 CD53 ARAP2	3.22e-05	193	139	6	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	TRPM2 EMILIN2 CPM CSF2RA CSF3R CD53	3.32e-05	194	139	6	f09675cd472200363c458952f00d2e41990800ee
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	TRPM2 EMILIN2 CPM CSF2RA CD53 ARAP2	3.32e-05	194	139	6	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	distal-Hematologic-Myeloid_Dendritic_Type_1-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZDHHC7 CHRNA7 CSF2RA CCR7 LBHD1 ARAP2	3.32e-05	194	139	6	f0467d81063a9b19783906c456935ef8318b9b98
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	TRPM2 EMILIN2 CPM CSF2RA CD53 ARAP2	3.42e-05	195	139	6	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	ADGRG5 IL32 SYNE1 CYFIP2 PCNX1 ARAP2	3.42e-05	195	139	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPM4 ERVV-2 CD55 SLCO4C1 CD53 CCR7	3.42e-05	195	139	6	9c6bed8414633813e1655bbeaab682fb296958a9
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IL32 CYFIP2 CD6 CD53 CCR7 ARAP2	3.42e-05	195	139	6	8687b319f1f487fbef4ca075fad054751a641de6
ToppCell	human_hepatoblastoma-Inflammatory_Monocytes\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	FNIP2 TRPM2 EMILIN2 CPM CSF2RA CD53	3.42e-05	195	139	6	ba7f85e5307d96ac5ad7c952f8d094db9ca1790c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRPM2 EMILIN2 CD6 CSF2RA CSF3R CD53	3.42e-05	195	139	6	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ADGRG5 IL32 SYNE1 CYFIP2 PCNX1 ARAP2	3.52e-05	196	139	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG5 IL32 SYNE1 CYFIP2 PCNX1 ARAP2	3.52e-05	196	139	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 IL32 SYNE1 CYFIP2 CD6 ARAP2	3.52e-05	196	139	6	51c750a0fb2b87e17e62b984c91fb16f676d7e76
ToppCell	T_cells-GZMK+_T_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	IL32 EML4 CYFIP2 CD6 CD53 ARAP2	3.52e-05	196	139	6	fa5c7fec9e0dcd7e62ff64704bfdf2a3437a43ba
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADGRG5 IL32 SYNE1 CYFIP2 PCNX1 ARAP2	3.52e-05	196	139	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADGRG5 IL32 SYNE1 CYFIP2 PCNX1 ARAP2	3.52e-05	196	139	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	(05)_Ciliated\|World / shred by cell type and Timepoint	VWA3A TCTE1 SYNE1 CFAP54 KNDC1 DNAH6	3.62e-05	197	139	6	fee3cd16af8eea697cd64e8f64af505aaa2ac4b0
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IL32 EML4 HELB CD6 CD53 CCR7	3.62e-05	197	139	6	e60deb009238702110c3b0948778802df215ad74
ToppCell	T_cells-CCR7+_T_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	IL32 EML4 CYFIP2 CD6 CD53 CCR7	3.62e-05	197	139	6	904430779c42b51d3eec62cf0cdd501b17058d8b
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	USP18 IL32 SYNE1 HELB CD6 CCR7	3.62e-05	197	139	6	0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e
ToppCell	BAL-Mild-cDC_10\|Mild / Compartment, Disease Groups and Clusters	IL32 VAC14 CSF2RA CCR7 CHRFAM7A ARAP2	3.62e-05	197	139	6	c0550d41dd5619b369b590f3d6a61154dd7b2cab
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WNT5A CPM CYFIP1 CSF2RA CSF3R CD53	3.62e-05	197	139	6	50f994e0d4e69019ec92e164edf3e4e951333766
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	USP18 IL32 SYNE1 HELB CD6 CCR7	3.62e-05	197	139	6	b3876076684781fb8384117f2cf367d828985986
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-MAIT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ACER2 IL32 EML4 CD6 CD53 CCR7	3.72e-05	198	139	6	f26150ae3fee6b2df2a51efaefbcfeb27f725a65
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRG5 TRPM2 EMILIN2 CSF2RA CENPI BUB1B	3.72e-05	198	139	6	732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 EMILIN2 SIPA1 CSF2RA CSF3R CD53	3.83e-05	199	139	6	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FNIP2 SYNE1 CPM SLCO4C1 CSF3R LRP2	3.83e-05	199	139	6	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 EMILIN2 CPM SIPA1 CSF2RA CSF3R	3.83e-05	199	139	6	b818d46a39c8782188d82dc8931b8eec9d549dd1
ToppCell	Sepsis-ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, condition lineage and cell class	TRPM4 VLDLR CSF2RA PDE8B HHAT SEC13	3.83e-05	199	139	6	90ddd686b8f39c6f6134b9b048396cebcf8d0448
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 EMILIN2 CPM SIPA1 CSF2RA CSF3R	3.83e-05	199	139	6	98c0d57c247d39bc771d81f4387f8dd01222628e
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IL32 EML4 CYFIP2 HELB CD6 CD53	3.83e-05	199	139	6	5a29db2610ba06a2248325a16cad755d20debf2c
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 RNF135 EMILIN2 CPM CSF2RA CSF3R	3.83e-05	199	139	6	9545ac59c8d75f5747dff86cb511a149dc103b31
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CD55 SLCO4C1 CSF3R BAZ1A WDFY3	3.83e-05	199	139	6	b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 EMILIN2 CPM CSF2RA CSF3R CD53	3.93e-05	200	139	6	700960201ae0df2c79e2907f5a0f95d73f8034fe
ToppCell	Tracheal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 EMILIN2 CPM CSF2RA CSF3R CD53	3.93e-05	200	139	6	ad7ae5106141669b353800fece833b3cd5bdccee
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPM2 EMILIN2 CPM CSF2RA CSF3R CD53	3.93e-05	200	139	6	f3dc07a7cc8cf041da8fe610d21af595818cf2d8
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PLXDC1 CCN4 SLCO4C1 PDE8B SUSD5 KCNS3	3.93e-05	200	139	6	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	WNT5A MUC5B CHRNA7 LIMK2 PIK3C2G WDR86	3.93e-05	200	139	6	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PLXDC1 CCN4 SLCO4C1 PDE8B KCNS3 WDR86	3.93e-05	200	139	6	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNE1 CFAP54 PIEZO2 STC2 SUSD5 CCN2	3.93e-05	200	139	6	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PLXDC1 CCN4 SLCO4C1 PDE8B KCNS3 WDR86	3.93e-05	200	139	6	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SYNE1 CD55 SLCO4C1 CSF3R BAZ1A WDFY3	3.93e-05	200	139	6	808571d74bb5c4d765ff13fc9393f88020d4e90d
ToppCell	Bronchus_Control_(B.)-Immune-TX-DCs\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	FNIP2 ADGRG5 TRPM2 EMILIN2 CSF2RA CD53	3.93e-05	200	139	6	e0beacb88bbdc353a3e883171613027feafcf1ef
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	PLXDC1 CCN4 SLCO4C1 PDE8B KCNS3 WDR86	3.93e-05	200	139	6	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYNE1 CFAP54 PIEZO2 STC2 SUSD5 CCN2	3.93e-05	200	139	6	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PLXDC1 CCN4 PDE8B KCNS3 CCN2 WDR86	3.93e-05	200	139	6	cf883ba5dbe6350b93142d625a52b25ff2a8bb63
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	GRB7 MALRD1 CD6 STC2 ARAP2	6.81e-05	136	139	5	5e209185b5f6e9347829fc9066f0b2c3711df057
ToppCell	P03-Hematopoietic\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ADGRG5 EMILIN2 SLC9A4 CD53 CCR7	8.08e-05	141	139	5	4a856521520ea73291f4730fe94c5de88c2b6f0c
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SPTBN2 TUT1 CFAP54 RASL11B DNAH6	8.64e-05	143	139	5	cc396b81a5e47d78c2d1cb49d682391376b63476
ToppCell	Control-Lymphocytic_NKT-iNKT/MAIT-T-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRG5 TRIM67 CD53 TRPM8 ARAP2	1.02e-04	148	139	5	003e10bf477984248211b99d75daa8f7dcdb12c8
ToppCell	P03-Hematopoietic-Immune-immune_cell_unspecified\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ADGRG5 EMILIN2 SLC9A4 CD53 CCR7	1.05e-04	149	139	5	43d756f81d532b5c7f2306e6af9d072d496cbc8e
ToppCell	P03-Hematopoietic-Immune\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ADGRG5 EMILIN2 SLC9A4 CD53 CCR7	1.05e-04	149	139	5	1c5a2572741c47246d455c865e8e1677c9f49598
Disease	Schizophrenia	VLDLR DRD3 MAP6 SPTBN2 CHRNA7 BRAP CYFIP1 CSF2RA HHAT ERVK-8 LRP2 KCNS3 TNFRSF1A NRG3 CHRFAM7A	1.12e-05	883	133	15	C0036341
Disease	nicotine dependence (implicated_via_orthology)	DRD3 CHRNA7 CHRFAM7A	1.91e-05	12	133	3	DOID:0050742 (implicated_via_orthology)
Disease	chromosome 15q11.2 deletion syndrome (implicated_via_orthology)	CYFIP2 CYFIP1	6.03e-05	3	133	2	DOID:0060393 (implicated_via_orthology)
Disease	anorectal malformation	TRPM2 MUC5B SUSD5	8.23e-05	19	133	3	MONDO_0019938
Disease	irritable bowel syndrome symptom measurement	TRPM2 CHRNA7 TRIM67 CHRFAM7A	1.39e-04	58	133	4	EFO_0021536
Disease	3-dehydrocarnitine measurement	MARCHF8 CSF3R	2.00e-04	5	133	2	EFO_0021037
Disease	schizophrenia (implicated_via_orthology)	MAP6 CHRNA7 NRG3 CHRFAM7A	2.57e-04	68	133	4	DOID:5419 (implicated_via_orthology)
Disease	cognitive disorder (implicated_via_orthology)	CHRNA7 CHRFAM7A	2.99e-04	6	133	2	DOID:1561 (implicated_via_orthology)
Disease	rheumatoid arthritis (biomarker_via_orthology)	CHRNA7 CHRFAM7A	2.99e-04	6	133	2	DOID:7148 (biomarker_via_orthology)
Disease	Child Development Disorders, Specific	PNKP LRP2 TBCD	3.00e-04	29	133	3	C0085997
Disease	Child Development Deviations	PNKP LRP2 TBCD	3.00e-04	29	133	3	C0085996
Disease	Developmental Disabilities	PNKP LRP2 TBCD	3.32e-04	30	133	3	C0008073
Disease	Severe Congenital Microcephaly	PNKP BUB1B TBCD	3.67e-04	31	133	3	C3853041
Disease	Microlissencephaly	PNKP BUB1B TBCD	4.42e-04	33	133	3	C1956147
Disease	Generalized seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0234533
Disease	Clonic Seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0234535
Disease	Convulsive Seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0751494
Disease	Seizures, Sensory	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0751496
Disease	Non-epileptic convulsion	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0751056
Disease	Atonic Absence Seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0751123
Disease	Complex partial seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0149958
Disease	Single Seizure	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0751110
Disease	Nonepileptic Seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C3495874
Disease	Visual seizure	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0270824
Disease	Epileptic drop attack	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0270846
Disease	Vertiginous seizure	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0422855
Disease	Gustatory seizure	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0422854
Disease	Seizures, Somatosensory	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0422850
Disease	Olfactory seizure	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0422853
Disease	Seizures, Auditory	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0422852
Disease	Generalized Absence Seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C4505436
Disease	Jacksonian Seizure	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C0022333
Disease	Epileptic Seizures	PNKP DRD3 CHRNA7 TBCD	1.15e-03	101	133	4	C4317109
Disease	Absence Seizures	PNKP DRD3 CHRNA7 TBCD	1.19e-03	102	133	4	C4316903
Disease	Convulsions	PNKP DRD3 CHRNA7 TBCD	1.19e-03	102	133	4	C4048158
Disease	Tonic Seizures	PNKP DRD3 CHRNA7 TBCD	1.19e-03	102	133	4	C0270844
Disease	Seizures, Focal	PNKP DRD3 CHRNA7 TBCD	1.28e-03	104	133	4	C0751495
Disease	Myoclonic Seizures	PNKP DRD3 CHRNA7 TBCD	1.28e-03	104	133	4	C4317123
Disease	Tonic - clonic seizures	PNKP DRD3 CHRNA7 TBCD	1.28e-03	104	133	4	C0494475
Disease	Lenticulostriate Disorders	DRD3 PDE8B	1.29e-03	12	133	2	C0750951
Disease	Extrapyramidal Disorders	DRD3 PDE8B	1.29e-03	12	133	2	C0015371
Disease	Basal Ganglia Diseases	DRD3 PDE8B	1.29e-03	12	133	2	C0004782
Disease	liver cirrhosis (implicated_via_orthology)	FOCAD CCN2	1.52e-03	13	133	2	DOID:5082 (implicated_via_orthology)
Disease	male infertility (implicated_via_orthology)	TCTE1 ARMC2	1.52e-03	13	133	2	DOID:12336 (implicated_via_orthology)
Disease	puberty onset measurement	PRICKLE4 TRPM2 CYFIP2 MKLN1	2.51e-03	125	133	4	EFO_0005677
Disease	cystic fibrosis (is_marker_for)	MUC5B CSF3R TLR5	2.79e-03	62	133	3	DOID:1485 (is_marker_for)
Disease	behavior or behavioral disorder measurement, personality trait	INTS7 KCNS3	2.94e-03	18	133	2	EFO_0004365, EFO_0004782
Disease	Usual Interstitial Pneumonia	WNT5A MUC5B	3.28e-03	19	133	2	C4721509
Disease	Hamman-Rich Disease	WNT5A MUC5B	3.28e-03	19	133	2	C4721508
Disease	peripheral neuropathy, response to docetaxel trihydrate	TRPM2 VAC14	3.28e-03	19	133	2	EFO_0003100, GO_1902519
Disease	Microcephaly	PNKP BUB1B TBCD	3.47e-03	67	133	3	C0025958
Disease	Familial Idiopathic Pulmonary Fibrosis	WNT5A MUC5B	3.63e-03	20	133	2	C4721952
Disease	amino acid measurement	IMPG1 SYNE1 CFAP20DC CD6 SUSD5 HHAT LRP2 SENP6 NRG3	3.70e-03	678	133	9	EFO_0005134
Disease	Idiopathic Pulmonary Fibrosis	WNT5A MUC5B	4.00e-03	21	133	2	C1800706

Protein segments in the cluster

Peptide	Gene	Start	Entry
VNCCARETSLAENIW	BUB1B	501	O60566
DREVSCNFERDTCSW	MAMDC4	651	Q6UXC1
SFHSQCLQRWDDTTC	BRAP	286	Q7Z569
AEFAQVTNWSSCCLR	AAAS	141	Q9NRG9
LQNCCRALWNFTQEL	CFAP54	1636	Q96N23
TKAAWDSIQSFLQCC	CD53	131	P19397
NCRLFTCIDSTFNWQ	ERVK-18	296	O42043
FQLQCDWNTSDFCIT	ERVK-18	436	O42043
ENCRLLTCIDSTFNW	ERVK-19	406	O71037
ENCRLLTCIDSTFNW	ERVK-8	406	Q902F8
RFQLQCDWNTSDFCI	ERVK-8	546	Q902F8
NCRLLTCIDSTFNWQ	ERVK-9	406	Q9UKH3
FQLQCDWNTSDFCIT	ERVK-9	546	Q9UKH3
CWISDRAFCELLSSF	ACER2	191	Q5QJU3
LICCFGNTSWDRSLL	BCDIN3D	246	Q7Z5W3
QLACLVCKTLWNFSE	ARMC2	776	Q8NEN0
CLSQEQLRQWSSCRH	CCR7	346	P32248
CQCSWRTIEEVTDLQ	CFAP418	181	Q96NL8
LSNCWICHNFITRSS	ERVV-2	41	B6SEH9
IWFNESNRSCADCKA	ARAP2	691	Q8WZ64
SRQVLWINACFCNLS	CCN4	331	O95388
VTQSCNTDCELRWHV	ADAMTS20	896	P59510
RFRCQDESEAVCSEW	CHRNA7	446	P36544
FERTILCNSLVWSCA	BAZ1A	41	Q9NRL2
RWCFYSSCEQLDQLI	BAZ1A	891	Q9NRL2
DCLVCVNLSHWSLQT	C16orf46	101	Q6P387
VNETWTLENCTVARC	MUC5B	5016	Q9HC84
DEKWLCRQCVFATTT	MTF2	146	Q9Y483
RQWCNCAFLESSAKS	RAP1A	136	P62834
QVNWDCNLDRAASLC	P2RX4	256	Q99571
TWSRENIQALCECAL	INTS7	286	Q9NVH2
ACATNNANLLAWTCL	PIK3C2G	566	O75747
TLSNCSWRFNNSNLC	CD6	336	P30203
ELRCSDCIVWNRQQT	NRG3	51	P56975
TLQQCCDLSQLWFRE	CYFIP1	611	Q7L576
KRSICLDQNTQAWCD	PAN2	706	Q504Q3
TANLIDSENYWLRCC	TCTE1	121	Q5JU00
CSLLLCNRNDTAWDE	MKKS	371	Q9NPJ1
CNRNDTAWDELKLTC	MKKS	376	Q9NPJ1
ITRACCIARFWNQLD	MAP6	6	Q96JE9
SCFRCSECQDSLTNW	LIMK2	36	P53671
WVSICQQETFCLFDI	IMPG1	126	Q17R60
SILTNQSNCWLCEHL	ERVMER34-1	36	Q9H9K5
ACWILEDTACLEATN	LBHD1	161	Q9BQE6
QWSDIEEFCNRSCEV	CD55	86	P08174
LSNCWICHNFITRSS	ERVV-1	41	B6SEH8
DIWVFQFCLVIASCQ	PCNX1	1031	Q96RV3
NCLKNLDLWCFDVFS	PDE1B	156	Q01064
VCEFLNCSETTLRAW	PDE8B	586	O95263
RFETISLQTWCSCVA	FAM205A	351	Q6ZU69
RSETISLQTWCSCVA	FAM205BP	81	Q63HN1
LALNSTWGCFCRQDL	GP2	201	P55259
TWGCFCRQDLNSSDV	GP2	206	P55259
VFCSICIDLWLKNNS	OBI1	36	Q5W0B1
LNATDLCLASCVWQD	FBXO8	86	Q9NRD0
LCLASCVWQDLANDE	FBXO8	91	Q9NRD0
LQQWIKSSDTRCCEL	MARCHF8	111	Q5T0T0
WGINELFIDSCCSNR	KCNS3	106	Q9BQ31
NDSRTCVEFDDCQIW	LRP2	341	P98164
LQQCCDLSQLWFREF	CYFIP2	636	Q96F07
LTTWLAISNSFCNCV	GPR52	301	Q9Y2T5
ENCRLLTCIDSTFNW	ERVK-7	1166	P63135
RFQLQCDWNTSDFCI	ERVK-7	1306	P63135
RFRCQDESEAVCSEW	CHRFAM7A	356	Q494W8
RIFCSEDEQSRTCWL	GRB7	316	Q14451
AFWLSACRSLDLCTQ	OXER1	321	Q8TDS5
CVAQFRSQLLTWLCS	HHAT	126	Q5VTY9
ACDQLIFSWRCTEAE	PRICKLE4	151	Q2TBC4
QTCFVTSFEWCSKRQ	FBXO17	146	Q96EF6
TFCCLWIACVFNSTL	MALRD1	16	Q5VYJ5
LCCATNEDRSWVFDS	GATD1	131	Q8NB37
LWSACTSQVTRLCDL	FZR1	211	Q9UM11
SLIECWIQDCQSLEI	DNAH6	3016	Q9C0G6
WCQLCLSSQHQAIER	IL32	56	P24001
FECSSHCSELSWRQN	KLHL11	71	Q9NVR0
IWAQCFEITLELSCC	CPM	271	P14384
NCRLLTCIDSTFNWQ	ERVK-24	296	P61566
FQLQCDWNTSDFCIT	ERVK-24	436	P61566
ENCRLLTCIDSTFNW	ERVK-25	406	P61570
RFQLQCDWNTSDFCI	ERVK-25	546	P61570
ENCRLLTCIDSTFNW	ERVK-6	406	Q69384
RFQLQCDWNTSDFCI	ERVK-6	546	Q69384
NCRLLSCIDSTFNWQ	ERVK-7	296	P61567
FQLQCDWNTSDFCIT	ERVK-7	436	P61567
RANCLVQTTEWSACS	CCN2	196	P29279
SWSCSEFDLNEIRLI	FNIP2	36	Q9P278
CLMNLTTSSLICQWE	CSF3R	131	Q99062
NCRLLTCIDSTFNWQ	ERVK-21	406	P61565
FQLQCDWNTSDFCIT	ERVK-21	546	P61565
SEQEAWAVCLECSLS	KNDC1	51	Q76NI1
ENCRLLTCIDSTFNW	HERVK_113	406	Q902F9
RFQLQCDWNTSDFCI	HERVK_113	546	Q902F9
LLLTCAQDRQVCLWN	EML4	606	Q9HC35
CCSQLEERWQRLQSQ	EMILIN2	666	Q9BXX0
WDGLCCRSQFLQLVS	CENPI	446	Q92674
QVTIIADDNCRFLCW	BVES	216	Q8NE79
EASWIAFCQCESLLQ	HELB	271	Q8NG08
NLSWDCQENTTFSKC	CSF2RA	46	P15509
LCQAEVVCIRSTWNA	FOCAD	636	Q5VW36
WNFSRICCDVFVTLD	DRD3	96	P35462
VIRCQFSTFEQCQEW	MTMR3	96	Q13615
NSLSCSEQLNRCIRW	RASL11B	96	Q9BPW5
IASCSQDGRVFIWTC	SEC13	231	P55735
TLESQNLFCCLYRSW	VAC14	611	Q08AM6
RWSCERFSTSQVLCS	RNF135	291	Q8IUD6
FSVLWLVSQNCCRAS	RNF133	21	Q8WVZ7
RETAFTLLCNSCGEW	SUSD5	176	O60279
NFCLWNEDTSTLQCH	TMEM140	51	Q9NV12
DQWLDLCRQSNNLCL	SYNE1	4216	Q8NF91
CSRNICSLVNWLKSF	LRRTM3	316	Q86VH5
FNCQCQTWKLLREDS	MKLN1	431	Q9UL63
LTECCGNSNLRFEIW	PLEKHG4	981	Q58EX7
SRSSDECVVALCDQW	LARS1	516	Q9P2J5
FVSFLDQRRWKCNLC	SEC24A	441	O95486
WCRDSTTDEQLFRCE	RABGGTA	341	Q92696
LQNTSCDRESCWKEN	PNLDC1	216	Q8NA58
ICFTLAFCQIWRAIS	SLC9A4	386	Q6AI14
VVFNCSCRDVIGWTS	SIPA1L2	891	Q9P2F8
NCACRDVLAWTFSEQ	SIPA1	631	Q96FS4
SWQRCVTTCETALKQ	PNKP	401	Q96T60
FCSSCGELQLWLEKQ	SPTBN5	901	Q9NRC6
LWFCSQRCRSEAEAK	ADGRG5	501	Q8IZF4
HNSCLRSWLEQDTSC	AMFR	361	Q9UKV5
IWCNLCIDLVAFTSE	CFAP20DC	6	Q6ZVT6
NLSDLFQWAVSRALC	CHST6	116	Q9GZX3
SRLDELNLSWCFDFT	SKP2	256	Q13309
LWFRCSLCSATAQNL	ZNF451	751	Q9Y4E5
EKCCTRNNSVTLAWR	TRIM67	521	Q6ZTA4
SWFTCFACSLRTQAQ	SUN5	71	Q8TC36
LSTQNWCAKCNLSFR	ZNF488	271	Q96MN9
WCAKCNLSFRLTSDL	ZNF488	276	Q96MN9
CRSKQGCQFDLDSIW	WDFY3	1801	Q8IZQ1
ELFAQSCCALESWLE	SPTBN2	1386	O15020
SCCALESWLESLQAQ	SPTBN2	1391	O15020
WAEICETFTRDACSL	RMND5B	261	Q96G75
FTIDSTCILWDINDC	SLCO4C1	636	Q6ZQN7
LSSLLAQFFSCVSCW	TUT1	491	Q9H6E5
IWAQSQDCIAAALAC	TRPM2	641	O94759
LNWQDTAVLAQCSEC	TRIM51	41	Q9BSJ1
CSSLDCTVRIWTAEN	WDR97	706	A6NE52
QCEQNWGSLCSILSF	STC2	196	O76061
NDWLALLSLSCCESR	TECPR1	706	Q7Z6L1
CRSCIQQSWLDLQEL	TRIM75	36	A6NK02
HNSCWLIQAFSLACT	PIEZO2	1376	Q9H5I5
LNTSDLTKCEWCNVR	SENP6	486	Q9GZR1
ALTWNNEIHCSFCET	USP50	236	Q70EL3
LECSCFRTSIWDETL	RRAGB	216	Q5VZM2
SCSLKTCWLQLADFR	WNT5A	246	P41221
TCQILHWNFTDIRCL	PKHD1L1	1281	Q86WI1
ETRQCQALVIWTDCD	TOP3A	136	Q13472
SLEEWQCLDCAQRNL	ZNF479	26	Q96JC4
LWVDAQSTCERECSR	WFIKKN1	41	Q96NZ8
DSNICLVSWEDIQCT	USP41	336	Q3LFD5
QFISCVRGQWTECSD	ZDHHC7	196	Q9NXF8
SICDVWLQLFSRDQA	SLC29A4	151	Q7RTT9
CSLRLWSLDNKTCVQ	STRN4	701	Q9NRL3
AEFLDWSLCNLARSS	TBCD	226	Q9BTW9
ASRIAFWCQENCVAL	WDR4	246	P57081
DSNICLVSWEDIQCT	USP18	336	Q9UMW8
SDLTFNCSWCHVLQR	PLXDC1	316	Q8IUK5
CQQCDKRFRWSSDLN	ZNF75A	191	Q96N20
SVCCFKNEDNETLAW	TRPM8	1041	Q7Z2W7
FICECELSTFINWLN	TLR5	581	O60602
FTCSADCTIRRWDVL	WDR86	71	Q86TI4
WSENLFQCFNCSLCL	TNFRSF1A	136	P19438
CEECGKSFSWRSRLQ	ZNF45	306	Q02386
ADSWNQCDLVALTCF	TRPM4	861	Q8TD43
WEQLRKCCDSFNLLS	VWA3A	986	A6NCI4
CSLKCQEEFWIRSNN	ZRANB3	936	Q5FWF4
SQFQCTNGRCITLLW	VLDLR	36	P98155